Characterization of Calcium Channel Binding

Wei Zheng1

1 Merck and Company, North Wales, Pennsylvania
Publication Name:  Current Protocols in Pharmacology
Unit Number:  Unit 1.25
DOI:  10.1002/0471141755.ph0125s14
Online Posting Date:  November, 2001
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library

Abstract

Voltage-dependent calcium channels are expressed in a variety of tissues including heart, muscles and brain. Saturation binding of a radioligand to the calcium channel is commonly used to characterize the expression level of the channel protein. Compound competition binding assay is a conventional screening method to determine the affinity of unlabeled compounds for the channel protein. This unit provides detailed experimental methods for two types of radioligand binding assays using [3H]PN200-100 and [125I](conotoxin MVIIA. Voltage-dependent calcium channels are expressed in a variety of tissues including heart, muscles and brain

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Unit Introduction
  • Basic Protocol 1: Measurement of [3H]PN200-100 Saturation Binding to L-type Calcium Channels in Cardiac Membranes
  • Basic Protocol 2: Measurement of [3H]PN200-100 Displacement Binding to L-type Calcium Channels in Cardiac Membranes
  • Basic Protocol 3: Measurement of [125I]-Conotoxin-MVIIA Saturation Binding to N-type Calcium Channels in Rat Brain Membranes
  • Basic Protocol 4: Measurement of Compound and [125I]-Conotoxin MVIIA Competition Binding to N-type Calcium Channels in Rat Brain Membranes
  • Commentary
  • Literature Cited
  • Figures
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

Basic Protocol 1: Measurement of [3H]PN200-100 Saturation Binding to L-type Calcium Channels in Cardiac Membranes

 Materials
  • Mouse or rat heart tissue (fresh or previously frozen)
  • L-type binding buffer: 50 mM Tris×Cl, pH 7.2 at room temperature, then chilled to be ice cold
  • [3H]PN200-100 (NEN Life Sciences)
  • 10 µM nitrendipine (for defining nonspecific binding) (ICN or Sigma)
  • L-type wash buffer: 5 mM Tris×Cl, pH 7.2 at room temperature, then chilled to be ice cold
  • Test compounds
  • Dissecting scissors
  • 50-ml centrifuge tubes
  • Polytron homogenizer (Brinkman)
  • Glass homogenizer with Teflon pestle and Tri-R Stir-R variable speed electric motor (Tri-R Instruments)
  • Cheesecloth (e.g., Grade 50; VWR Scientific)
  • 5-ml polypropylene test tubes
  • Glass fiber filters (GF/B type, Whatman)
  • Cell harvester (Brandel Instrument)
  • Scintillation vials
  • Scintillation fluid
  • -scintillation counter
  • Curve fitting programs (e.g., KELL, Biosoft; or Prism, GraphPad Software)

Basic Protocol 3: Measurement of [125I]-Conotoxin-MVIIA Saturation Binding to N-type Calcium Channels in Rat Brain Membranes

 Materials
  • Whole rat brain (fresh or previously frozen)
  • N-type binding buffer: 50 mM Tris×Cl with 0.1% BSA, pH 7.2 at room temperature, then chilled to be ice cold
  • [125I]-conotoxin-MVIIA (NEN Life Sciences)
  • -conotoxin-MVIIA (for defining nonspecific binding; Peninsula Laboratories)
  • Test compounds
  • 0.5% (w/v) polyethyleneimine (PEI)
  • N-type wash buffer: 5 mM Tris×Cl and 150 mM NaCl, pH 7.2 at room temperature, then chilled to be ice cold
  • 50-ml centrifuge tube
  • Glass homogenizer with Teflon pestle and Tri-R Stir-R variable speed electric motor (Tri-R Instruments)
  • 5-ml polypropylene test tubes
  • Polytron homogenizer
  • Glass fiber filters (GF/C type, Whatman)
  • Cell harvester (Brandel Instruments)
  • -scintillation counter
  • Curve fitting programs (e.g., KELL, Biosoft; or Prism, GraphPad Software)
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

  •  FigureFigure 1.25.1 (A) Saturation binding of [3H]PN200-100 to L-type calcium channels in mouse heart membrane preparation (n = 2). (B) Scatchard analysis of the specific binding data: Kd = 54.9 pM and Bmax = 116.4 fmol/mg protein.
    View Image
  •  FigureFigure 1.25.2 Inhibition of [3H]PN200-100 binding in mouse heart membrane preparation by nitrendipine and nifedipine (n = 2). The IC50 values are 408 and 728 pM for nitrendipine and nifedipine, respectively (Ki(nitrendipine) = 206 pM and Ki(nifedipine) = 367 pM).
    View Image
  •  FigureFigure 1.25.3 (A) Saturation binding of [125I] -conotoxin MVIIA to N-type calcium channels in rat brain membrane preparation (n = 2). (B) Scatchard analysis of the specific binding data: Kd = 17.9 pM and Bmax = 1503 fmol/mg protein.
    View Image
  •  FigureFigure 1.25.4 Inhibition of [125I] -conotoxin MVIIA binding to rat brain membrane preparation by -conotoxin MVIIA (n = 2). The IC50 value is 41.2 pM (Ki = 18.9 pM).
    View Image

Videos

Literature Cited

Literature Cited
    Alexander, S.P.H. and Peters, J.A. eds. 2000. Receptor and ion channel nomenclature. Trends Phys. Sci. 11:S98-S100.
    Bech-Hansen, N.T., Naylor, M.J., Maybaum, T.A., Pearce, W.G., Koop, B., Fishman, G.A., Mets, M., Musarella, M.A., and Boycott, K.M. 1998. Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. Nat. Genet 19:264-267.
    Cheng, Y.C. and Prusoff, W.H. 1973. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition of an enzyme reaction. Biochem.Pharmacol 23:3099-3108.
    Cribbs, L.L., Lee, J.-H., Yang, J., Satin, J., Zhang, Y., Daud, A., Barclay, J., Williamson, M.P., Fox, M., Rees, M. and Perez-Reyes, E. 1998. Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family. Circ. Res. 83:103-109.
    Delean, A., Munson, P.J., and Rodbard, D. 1978. Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curve. Am. J. Physiol. 235:E97-E102.
    Dubel, S.J., Starr, T.V.B., Hell, J., Ahlijanian, M.K., Enyeart, J.J., Catterall, W.A., and Snutch, T.P. 1992. Molecular cloning of the 1 subunit of an -conotoxin-sensitive calcium channel. Proc. Natl. Acad. Sci. U.S.A. 89:5058-5062.
    Ertel, E.A., Campbell, K.P., Harpold, M.M., Hofmann, F., Mori, Y., Perez-Reyes, E., Schwartz, A., Snutch, T.P., Tanabe, T., Birnbaumer, L., Tsien, R.W., and Catterall, W.A. 2000. Nomenclature of voltage-gated calcium channels. Neuron 25:533-535.
    Lee, J.H., Daud, A.N. Cribbs, L.L., Lacerda, A.E., Pereverzev, A., Klockner, U., Schneider, T., and Perez-Reyes, E. 1999. Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family. J. Neurosci. 19:1912-21
    Mikami, A., Imoto, K., Tanabe, T., Niidome, T., Mori, Y., Takeshima, H., Narumiya, S., and Numa, S. 1989. Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel. Nature 340:230-233.
    Mori, Y., Friedrich, T., Kim, M.-H., Mikami, A., Nakai, J., Ruth, P., Bosse, E., Hofmann, F., Flockerzi, V., Furuichi., T., Mikoshiba, K., Imoto, K., Tanabe, T., and Numa, S. 1991. Primary structure and functional expression from complementary DNA of a calcium channel. Nature 350:398-402.
    Munson, P.J. and Rodbard, D. 1980. A versatile computerized approach for characterization of ligand binding system. Anal. Biochem. 107:220-239.
    Perez-Reyes, E., Cribbs, L.L., Daud, A., Lacerda, A.E., Barclay, J., Williamson, M.P., Fox, M., Rees, M., and Lee, J.H. 1998. Molecular characterization of a neuronal low-voltage-activated T-type calcium channel. Nature 391:896-900
    Snutch, T.P., Tomlinson, W.J., Leonard, J.P., and Gilbert, M.M. 1991. Distinct calcium channels are generated by alternative splicing and are differentially expressed in the mammalian CNS. Neuron 7:45-57.
    Stoehr, S.J. and Dooley, D.J. 1993. Characteristics of [125I]omega-conotoxin MVIIA binding to rat neocortical membranes. Neurosci Lett. 161:113-116
    Strom, T.M., Nyakatura, G., Apfelstedt, S-E., Hellebrand, H., Lorenz, B., Weber, B.H., Wutz, K., Gutwillinger, N., Ruther, K., Drescher, B., Sauer, C., Zrenner, E., Meitinger, T., Rosenthal, A., and Meindl, A. 1998. An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat. Genet. 19:260-263.
    Tanabe, T., Takeshima, H., Mikami, A., Flockerzi, V., Takahashi, H., Kangawa, K., Kojima, M., Matsuo, H., Hirose, T., and Numa, S. 1987. Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature 328:313-318.
    Wagner, J.A., Snowman, A.M., Biswas, A., Olivera, B.M., and Snyder, S.H. 1988. -Conotoxin GVIA binding to a high affinity receptor in brain: characterization, calcium sensitivity, and solubilization. J. Neurosci. 8:3354-3359.
    Williams, M.E., Brust, P.F., Feldman, D.H., Patthi, S., Simerson, S., Maroufi, A., McCue, A.F., Velicelebi, G., Ellis, S.B., and Harpold, M.M. 1992. Structure and functional expression of an –conotoxin-sensitive human N-type calcium channel. Science 257:389-395.
    Williams, M.E., Feldman, D.H., McCue, A.F., Brenner, R., Velicelebi, G., Ellis, S.B., and Harpold, M.M. 1992. Structure and functional expression of 1, 2, and subunits of a novel human calcium channel subtype. Science 257:389-395.
    Zheng, W., Hawthorn, M., and Triggle, D.J. 1991. Thermodynamic and kinetic aspects of agonist and antagonist binding to 1,4-dihydropyridine receptor. Eur. J. Pharmacol. 208:137-147.
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library